Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma
Clinical trial NCT03465891 · TERMINATED
Trial details
- NCT number
- NCT03465891
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-09
- Primary completion
- 2019-12-17
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.